Funded by multiple grants, alum Russ Lehrman (PhD ‘81) is developing a new therapeutic to revolutionize pulmonary care, starting with preterm infants.
Research
School of Pharmacy Researchers Earn 2022 Best Paper Award for Pioneering CancelRx Study
The winning paper by Professor Michelle Chui, alum Taylor Watterson (MS ’18, PhD ’22) and collaborators explores impactful changes to pharmacist and prescriber workflow.
Killing Infection with Infection
Through new NIH grant, School of Pharmacy Assistant Professor Jason Peters and collaborators are investigating bacteria viruses as a way to defeat antibiotic resistance.
Two First-in-Kind Clinical Trials Explore Psilocybin for Substance Misuse
Professor Paul Hutson and collaborators in the Transdisciplinary Center for Research in Psychoactive Substances study psilocybin for opioid and methamphetamine use disorders.
Pharmacy Experts Webinar: Psychedelic Medicine, Pharmacy & Society
Watch as Associate Professor Lucas Richert, of the Social and Administrative Sciences Division, and Professor Paul Hutson and Assistant Professor Cody Wenthur, both of the Pharmacy Practice and Translational Research Division, discuss where psychedelic research is today, what projects are underway here at UW–Madison, and how the role of pharmacists factors in.
A Continuing Tradition of Innovation
School of Pharmacy researchers in fiscal year 2021–22 received four patents for innovations in drug discovery and delivery.
Digitizing Centuries of Pharmaceutical and Pharmacy History
A three-year grant from the National Endowment for the Humanities helps the School and AIHP share vast historical collections By Ben Cadigan Where would you look to find a Martian-themed booklet advertising products from the …
Exploring New Avenues for Targeted Protein Degradation
Supported by a prestigious national fellowship and UW traineeship, Pharmaceutical Sciences graduate student Christopher Stevens is expanding the application of a future therapeutic.
New Approach Could Push Limits of Immunotherapy for Difficult-to-Treat Cancers
A recent study by Assistant Professor Quanyin Hu points toward a potential new approach for pushing the limits of immunotherapy, opening a door to more effective treatment of inoperable tumors and metastatic cancer.
Probiotic ‘Backpacks’ Show Promise for Treating Inflammatory Bowel Diseases
Combined with the probiotics themselves, newly developed nanoparticle “backpacks” could significantly improve — and simplify — IBD treatments.